Latest News
A recent study on the relationship between the huntingtin mutation and astrocytes has revealed that inhibition of the mutation in the glial cells could stop disease progression.
A low-cost and widely available drug, termed tranexamic acid, could reduce deaths from traumatic brain injury by ‘hundreds of thousands’, according to a recent study.
Researchers have suggested that traumatic microbleeds may be a form of injury to brain blood vessels that could predict worse outcomes following a head injury.
Journal Articles
In this interview from the Video Journal of Biomedicine, Hannah Brown (Ipsos Healthcare, London, UK) discusses physician and patient treatment decision-making for relapsing–remitting multiple sclerosis.
Take a look behind the scenes of a study published in Brain, as we ask Dr Ryan D’Arcy about the establishment of brain vital signs for concussion-related impairments.
Discover more about an ongoing, multicenter registry that provides real-world evidence regarding ataluren use in nonsense mutation Duchenne muscular dystrophy patients in this research article.
Autoimmune
Could hyaluronic acid contribute to chronic white matter injury?
Can living in a sunnier climate in your youth reduce the risk of MS?
Cerebrovascular disease
Traumatic microbleeds may predict worse outcomes following head injury
Blood pressure changes in mid-30s linked to poorer brain health
Age-related cognitive changes may be reduced with intensive blood pressure control
CNS/PNS/SNS
Neuroprosthetic exoskeleton allows tetraplegic patient to utilize his limbs
Traumatic CNS injury and the inflammatory stem cell niche: an interview with Aileen Anderson
Electrical patterns in ‘mini-brains’ can’t be distinguished from premature babies, study reveals
Cognitive/neurodegenerative disorders
Astrocytes identified as potential therapeutic target for the treatment of Huntington's disease
Deactivating microglia reduces tau-linked brain damage in mice, study reveals
Signs of dementia may be detected earlier in women with new diagnostic criteria
Demyelinating disease
Unraveling the heterogeneity of oligodendrocytes with Ana Mendanha Falcão
Development and pediatrics
A new perspective on the development of neural circuits in embryos
Researchers challenge the ‘extreme male brain’ theory of autism
Epilepsy and seizure
Epidyolex® receives marketing authorization from the EMA for seizures
Genetics
Genetic therapies for neurodegenerative diseases: an interview with Sarah Tabrizi
Brain architecture linked to genetic regions in left-handed people
Headache
Emgality® achieves primary and secondary outcomes in Phase III trial for migraines
Acute migraine: novel therapy shows promise in Phase III trial
Why are migraines more common in women? New sex-specific insights revealed
Immune disorders and inflammation
Inflammatory disease and anxiety: could endocannabinoids be a mechanism of comorbidity?
FENS 2018: Immune system offers new way of treating Alzheimer’s disease
FENS 2018: Could anxiety and inflammation be treated with cannabis?
Infection
Could a bacterial polysaccharide suppress fatal brain inflammation?
Link between Alzheimer’s disease and periodontal bacteria gains traction
Injury/trauma
Tranexamic acid could reduce head injury deaths by ‘hundreds of thousands’
Traumatic microbleeds may predict worse outcomes following head injury
Traumatic CNS injury and the inflammatory stem cell niche: an interview with Aileen Anderson
Movement disorders
Neuroprosthetic exoskeleton allows tetraplegic patient to utilize his limbs
Parkinson’s progression could be slowed down by drug that treats enlarged prostate
Ofatumumab demonstrates superiority over Aubagio® for relapsing MS: industry news round-up
Neuro-ophthalmology
Gene therapy breakthrough allows mice to regain sight
Could an eye scan detect signs of Alzheimer's disease?
Vision in Alzheimer's disease: a focus on the anterior afferent pathway
Neurometabolic
Epigenetics, opioids and immune regulation: interviews from SfN17
Jeffrey Iliff: glymphatics, Alzheimer’s and future directions
SfN17: Neurodegeneration and the microbiome – new research highlights
Neuromuscular
New genetic suspects identified for ALS and FTD
Novel discovery in motor neuron disease may pave the way for future treatments
Neuropsychiatry
World Mental Health Day: facts, figures and the flaws of academia
Could psychiatric disorders be triggered by air pollution?
Addiction: a compulsive interplay between drugs, cues and habits
Oncology/tumor
High-grade gliomas may hijack signals from neurons to drive their own growth
Glioblastoma: could a blood test be on the horizon?
Veledimex: a drug-inducible gene therapy approach for glioblastoma yields promising Phase I results
Pain
Emgality® achieves primary and secondary outcomes in Phase III trial for migraines
Advances in migraine genetics, neurobiology and treatment
Acute migraine: novel therapy shows promise in Phase III trial
Sleep
Could circadian rhythms influence immune response efficiency in mice?
Could how much you sleep depend on your genes?
Acute light exposure at night doesn’t affect circadian rhythm in mice, research suggests
